Telix Pharmaceuticals Limited Revenue and Competitors
Estimated Revenue & Valuation
- Telix Pharmaceuticals Limited's estimated annual revenue is currently $69.3M per year.
- Telix Pharmaceuticals Limited's estimated revenue per employee is $155,000
Employee Data
- Telix Pharmaceuticals Limited has 447 Employees.
- Telix Pharmaceuticals Limited grew their employee count by 37% last year.
Telix Pharmaceuticals Limited's People
Name | Title | Email/Phone |
---|---|---|
1 | CEO Americas | Reveal Email/Phone |
2 | CEO Telix Asia Pacific | Reveal Email/Phone |
3 | CFO Americas | Reveal Email/Phone |
4 | CFO EMEA | Reveal Email/Phone |
5 | Group Chief Commercial Officer (CCO) | Reveal Email/Phone |
6 | VP Marketing | Reveal Email/Phone |
7 | Head Global Commercialization | Reveal Email/Phone |
8 | Interim VP | Reveal Email/Phone |
9 | VP - Urologic Oncology Commercialization | Reveal Email/Phone |
10 | Area VP - Oncology - Central U.S. | Reveal Email/Phone |
Telix Pharmaceuticals Limited Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $52.4M | 338 | 28% | N/A | N/A |
#2 | $13.8M | 89 | 9% | N/A | N/A |
#3 | $18.6M | 120 | 21% | N/A | N/A |
#4 | $17.1M | 110 | -1% | N/A | N/A |
#5 | $48.1M | 310 | 6% | N/A | N/A |
#6 | $15.3M | 99 | 27% | N/A | N/A |
#7 | $13.6M | 88 | -14% | N/A | N/A |
#8 | $15.5M | 100 | 9% | N/A | N/A |
#9 | $19.7M | 127 | 8% | N/A | N/A |
#10 | $21.2M | 137 | -4% | $33.8M | N/A |
What Is Telix Pharmaceuticals Limited?
Telix is a biopharmaceutical company focused on the development of diagnostic and therapeutic products using Molecularly Targeted Radiation (MTR). Telix is headquartered in Melbourne, Australia with international operations in Belgium, Japan, and the United States. Telix is developing a portfolio of clinical-stage products that address significant unmet medical need in oncology and rare diseases. Telix is listed on the Australian Securities Exchange (ASX: TLX).
keywords:N/AN/A
Total Funding
447
Number of Employees
$69.3M
Revenue (est)
37%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Telix Pharmaceuticals Limited News
MELBOURNE, Australia and LIÈGE, Belgium, April 22, 2022 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today...
MELBOURNE, Australia and INDIANAPOLIS, March 28, 2022 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that the...
MELBOURNE, Australia and INDIANAPOLIS, April 10, 2022 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, "Telix", the "Company") today...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $69.3M | 447 | 37% | N/A |
#2 | $114.8M | 457 | 2% | N/A |
#3 | $159.4M | 949 | 6% | N/A |
#4 | $279.1M | 992 | 2% | N/A |